Aimmune Therapeutics Reports Positive Findings for ARC002 Follow-On Phase 2 Study of AR101 for Treatment of Peanut Allergy by longitudeadmin | Nov 11, 2015 | Portfolio News
Multi-Center, Community-Based Patient Registry Interim Results Presented at the AHA Scientific Sessions Support the Clinical Utility of the Corus® CAD Test in the Assessment of Obstructive Coronary Artery Disease by longitudeadmin | Nov 10, 2015 | Portfolio News
Jazz Pharmaceuticals Announces Third Quarter 2015 Financial Results by longitudeadmin | Nov 9, 2015 | Portfolio News
Collegium Announces FDA Tentative Approval for Xtampza™ ER, a Novel Abuse-Deterrent Analgesic for Chronic Pain by longitudeadmin | Nov 9, 2015 | Portfolio News
Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Third Quarter 2015 Financial Results by longitudeadmin | Nov 5, 2015 | Portfolio News
